Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-25Clinical Trial Update: Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction [Phase 1]
Phase 1 pharmacokinetic study of oral ixazomib in cancer patients with liver dysfunction to assess exposure and safety.
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: A Phase I, Open-Labeled, Single-Arm, Dose Escalation, Clinical and Pharmacology Study of Dichloroacetate (DCA) in Patients With Recurrent and/or Metastatic Solid Tumours [Phase 1]
Phase I, open-label, single-arm dose-escalation study of dichloroacetate in patients with recurrent and/or metastatic solid tumors; the tria…
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies [Phase 2]
Phase 2 trial of Brentuximab Vedotin in CD30-positive non-lymphomatous malignancies has completed and results were posted in 2016. The study…
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma [Phase 1]
This report summarizes the completed Phase 1 dose-escalation safety study of TL32711 in adults with refractory solid tumors or lymphoma.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors [Phase 1]
A Phase 1 study evaluating continuous intravenous infusion of Terameprocol (EM-1421) in patients with refractory solid tumors and lymphoma w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-19Clinical Trial Update: Safety and Efficacy of Repeated Infusion of CELYVIR in Children and Adults With Metastatic and Refractory Tumors. [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating repeated infusion of CELYVIR in children and adults with metastatic and refractory solid tum…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients [Phase 1]
Phase I dose-escalation study of SAR125844 in Asian patients with solid tumors has been completed.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006) [Phase 1]
Phase 1 trial of robatumumab (SCH 717454, MK-7454) in combination with different regimens in pediatric participants with advanced solid tumo…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update from Chinese PLA General Hospital evaluating treatment of chemotherapy-refractory HER2-positive advanced s…
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Lower Dose Decitabine Based Therapy in Patients With Refractory and/or Chemotherapy Resistant Solid Tumors or B Cell Lymphomas [Phase 1, Phase 2]
Clinical trial update on a lower-dose decitabine-based therapy for patients with refractory or chemotherapy-resistant solid tumors and B-cel…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours [Phase 2]
This Phase 2 trial update notes the completion of studies evaluating temozolomide in combination with topotecan for refractory and relapsed …
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies [Phase 1]
A Phase 1 safety study of Clostridium novyi-NT spores for solid tumors has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-12-04Clinical Trial Update: A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer [Phase 1]
This clinical trial update reports completion of a Phase 1 pivotal bioequivalence study of the liposomal doxorubicin formulation DOXIL/CAELY…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: Clinical Trial of the Combination of Trastuzumab (Herceptin) and Tanespimycin in Patients With Solid Tumors and Her2 Positive Metastatic Breast Cancer That Have Previously Failed Herceptin [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated the combination of trastuzumab (Herceptin) and tanespimycin in patients with solid tumors and HER2-pos…
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid Tumors [Phase 1]
This Phase 1 dose-escalation trial assesses ombrabulin in combination with paclitaxel and carboplatin in patients with advanced solid tumors…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors [Phase 1]
A Phase 1 clinical trial assessing the combination of everolimus and bevacizumab in pediatric patients with recurrent solid tumors and CNS m…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) [Phase 1, Phase 2]
This clinical trial update reports termination of a Phase 1/2 study of Epofolate (BMS-753493) in subjects with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 1) [Phase 1, Phase 2]
Phase 1/2 study of Epofolate (BMS-753493) in advanced solid tumors was terminated, with the trial status showing TERMINATED.
-
CLINICAL_TRIALS withdrawal · 2015-10-07Clinical Trial Update: A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study of PF-03084014 in Japanese patients with advanced solid tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Japan PhI/II of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600E/K Mutation Positive Advanced Solid Tumors (Phase I Part) or Cutaneous Melanoma (Phase II Part) [Phase 2]
Phase I/II trial update from Japan evaluating the dabrafenib and trametinib combination in patients with BRAF V600 mutation-positive advance…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of Trebananib (AMG 386) in adult Japanese participants with advanced sol…
-
CLINICAL_TRIALS trial_result · 2015-09-22Clinical Trial Update: Study of Vinorelbine Liposomes Injection for Advanced Solid Tumors, Non-Hodgkin's Lymphoma or Hodgkin's Disease [Phase 1]
Phase 1 study of Vinorelbine Liposome Injection for advanced solid tumors, Hodgkin lymphoma, and Non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS other · 2015-09-02Clinical Trial Update: A Dose-Escalating Study of RO4987655 in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 dose-escalation trial of RO4987655 in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED) [Phase 1]
A completed Phase 1 safety study of ridaforolimus (MK-8669) in patients with advanced, refractory or recurrent malignancies, including lymph…
-
CLINICAL_TRIALS research · 2015-08-27Clinical Trial Update: Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
This clinical trial update describes the experiences of 6- to 12-year-old pediatric cancer patients balancing school attendance with ongoing…